Cleared Traditional

K012649 - RAICHEM BUN RATE REAGENT

K012649 is the FDA 510(k) clearance for RAICHEM BUN RATE REAGENT by Hemagen Diagnostics, Inc.. It is a Class 2 Chemistry device (product code CDQ) cleared through the Traditional 510(k) pathway after a 63-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2001
Decision
63d
Days
Class 2
Risk

K012649 is an FDA 510(k) clearance for the RAICHEM BUN RATE REAGENT. Classified as Urease And Glutamic Dehydrogenase, Urea Nitrogen (product code CDQ), Class II - Special Controls.

Submitted by Hemagen Diagnostics, Inc. (Columbia, US). The FDA issued a Cleared decision on October 15, 2001 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1770 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hemagen Diagnostics, Inc. devices

Submission Details

510(k) Number K012649 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 2001
Decision Date October 15, 2001
Days to Decision 63 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 88d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CDQ Urease And Glutamic Dehydrogenase, Urea Nitrogen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CDQ Urease And Glutamic Dehydrogenase, Urea Nitrogen

All 87
Devices cleared under the same product code (CDQ) and FDA review panel - the closest regulatory comparables to K012649.
EASYRA UREA NITROGEN AND CREATININE REAGENTS
K110675 · Medica Corp. · Apr 2011
TECO CX3 REAGENT SET FOR SYNCHRON CX SYSTEM
K060120 · Teco Diagnostics · Mar 2006
RAICHEM BUN RATE REAGENT (LIQUID)
K041051 · Hemagen Diagnostics, Inc. · Jun 2004
UREA-L3K ASSAY, CATALOGUE NUMBER 283-17/30
K002694 · Diagnostic Chemicals , Ltd. · Sep 2000
WAKO L-TYPE UN TEST
K993925 · Wako Chemicals USA, Inc. · Apr 2000
UREA-L3K ASSAY, CATALOGUE NUMBER 283-17/10/30/50
K993178 · Diagnostic Chemicals , Ltd. · Oct 1999